🇺🇸 Cerezyme in United States

FDA authorised Cerezyme on 23 May 1994

Marketing authorisations

FDA — authorised 23 May 1994

  • Marketing authorisation holder: GENZYME
  • Status: approved

FDA — authorised 5 September 2014

  • Application: BLA020367
  • Marketing authorisation holder: GENZYME
  • Indication: Manufacturing (CMC)
  • Status: approved

Read official source →

Cerezyme in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Cardiovascular approved in United States

Frequently asked questions

Is Cerezyme approved in United States?

Yes. FDA authorised it on 23 May 1994; FDA authorised it on 5 September 2014.

Who is the marketing authorisation holder for Cerezyme in United States?

GENZYME holds the US marketing authorisation.